H.R. 2040 (119th)Bill Overview

NEWBORN Act

Health|Health
Cosponsors
Support
Lean Democratic
Introduced
Mar 11, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Energy and Commerce.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill amends the Public Health Service Act to authorize HRSA-administered infant mortality pilot program grants in metropolitan areas and high-rate counties. Grants last up to five years, prioritize the 50 counties (or groups) with highest infant mortality, fund outreach, clinical and social services, rural outreach, and public education, and require annual reporting and evaluation.

Why people may split

Adequacy of funding: liberal sees insufficient, conservatives see wasteful federal spending

Watch point

Relative to its intended legislative type, this bill establishes a clear statutory authorization for infant mortality pilot grants, integrates into the Public Health Service Act, and provides basic implementation elements (administrator, grant period, eligible entities, allowable uses, preference criteria, reporting, and funding authorization).

The bill amends the Public Health Service Act to authorize HRSA-administered infant mortality pilot program grants in metropolitan areas and high-rate counties.

Grants last up to five years, prioritize the 50 counties (or groups) with highest infant mortality, fund outreach, clinical and social services, rural outreach, and public education, and require annual reporting and evaluation.

It limits grantee evaluation spending to 10 percent and authorizes $10 million per year for FY2025–2029 to carry out the pilot programs.

Passage35/100

Substantively low‑controversy and low‑cost authorization improves prospects, but authorizations require later appropriations and must clear committee and procedural barriers.

CredibilityPartially aligned

Relative to its intended legislative type, this bill establishes a clear statutory authorization for infant mortality pilot grants, integrates into the Public Health Service Act, and provides basic implementation elements (administrator, grant period, eligible entities, allowable uses, preference criteria, reporting, and funding authorization).

Contention65/100

Adequacy of funding: liberal sees insufficient, conservatives see wasteful federal spending

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agenciesFederal agencies · Cities

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesProvides targeted federal grant funding to areas with the highest infant mortality rates.
  • Potential benefitSupports outreach and preventive services like counseling, postpartum care, and substance treatment programs.
  • Potential benefitExpands rural and Tribal outreach, potentially improving access in underserved communities.
Likely burdened
  • Potential burdenAuthorized funding level may be too small to meaningfully reduce infant mortality across many high-need counties.
  • Federal agenciesFive-year grant terms could create sustainability gaps when federal pilot funding ends.
  • CitiesAdministrative and annual reporting requirements may strain capacity of small health departments.
03 · Why people split

Why the argument around this bill splits.

Adequacy of funding: liberal sees insufficient, conservatives see wasteful federal spending
Progressive90%

Likely supportive; views the bill as a targeted federal investment addressing infant mortality and maternal-infant health disparities.

Sees value in funding services, outreach, rural access, and data collection to inform broader policy.

Leans supportive
Centrist70%

Generally favorable but cautious; appreciates targeted pilots and evaluation requirements while wanting clear metrics and avoidance of duplication.

Concerned funding adequacy and implementation details need scrutiny.

Leans supportive
Conservative30%

Skeptical; views the bill as an additional federal grant program expanding federal involvement in local health.

Accepts goal of reducing infant mortality but questions scope, ongoing spending, and federal management.

Likely resistant
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Substantively low‑controversy and low‑cost authorization improves prospects, but authorizations require later appropriations and must clear committee and procedural barriers.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether committee advances the bill to floor
  • Actual appropriations will match authorized amounts
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Adequacy of funding: liberal sees insufficient, conservatives see wasteful federal spending

Substantively low‑controversy and low‑cost authorization improves prospects, but authorizations require later appropriations and must clear…

Unlocked analysis

Relative to its intended legislative type, this bill establishes a clear statutory authorization for infant mortality pilot grants, integrates into the Public Health Service Act, and provides basic implementation elemen…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis